Xu Yu, MD, Ragon group leader, recently published a study entitled "Distinct viral reservoirs in individuals with spontaneous control of HIV-1," in Nature. Yu's lab, in collaboration with Ragon group leaders Mathias Lichterfeld, ...
Aug 26, 2020
0
43
Every year, more than 250,000 women in the U.S. are diagnosed with breast cancer. When detected early, patients with the most common form—which tests positive for hormone receptors (HR+) and negative for the HER2 receptor—usually ...
Aug 22, 2019
0
15
Gut microbes from high HIV-risk men who have sex with men drive immune activation in mice and HIV infection in cells, according to a study published April 4 in the open-access journal PLOS Pathogens by Brent Palmer and Catherine ...
Apr 4, 2019
0
25
A technique for studying individual circuits in the brains of mice has been hampered because the light needed to stimulate neural activity briefly overwhelms the electrodes "listening" for the response. Now, improved shielding ...
May 1, 2020
0
211
(Medical Xpress)—A team of researchers from the U.S. and Scotland has developed a new type of retinal prostheses designed to restore sight to blind patients. In their paper published in the journal Nature Communications, ...
For the first time, researchers have shown what happens to the brain when a person receives a depression treatment known as repetitive transcranial magnetic stimulation (rTMS). The results were published today in the American ...
May 18, 2022
0
95
Faster cancer treatments may be possible thanks to research from Children's Medical Research Institute (CMRI).
Oct 3, 2019
0
174
Like a team in a science fiction movie, the six-lab squad funded by a 2017 MEDx Biomedical research grant is striking in its combination of diverse skills and duties.
Aug 3, 2018
0
56
It's well known that regular physical activity has health benefits, including weight control, strengthening the heart, bones and muscles and reducing the risk of certain diseases. Recently, researchers at University of California ...
Jan 12, 2017
0
289
Acute myeloid leukemia (AML) is an aggressive cancer of white blood cells with few effective targeted therapies available to treat it. Cold Spring Harbor Laboratory (CSHL) Professor Christopher Vakoc and former graduate student ...
Jan 11, 2022
0
92
